Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death Without Definitive Causative Diagnosis (PEA-SuddenDeath)

NCT05446779 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.

NCT NCT05446779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05446779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death Without Definitive Causative Diagnosis (PEA-SuddenDeath)
Lead sponsor
Helsinki University Central Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
February 3, 2022
Completion date
December 31, 2026
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adrenal cushing syndrome, endocrine neoplasia, pheochromocytoma, primary aldosteronism